A Clinical Study to Evaluate the Efficacy, Safety, and Tolerability of TERN-601 in Adults With Overweight or Obesity
- First Posted Date
- 2025-03-03
- Last Posted Date
- 2025-05-14
- Lead Sponsor
- Terns, Inc.
- Target Recruit Count
- 150
- Registration Number
- NCT06854952
- Locations
- 🇺🇸
FALCON Research Site, Arlington, Virginia, United States
CARDINAL- A Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of TERN-701 in Participants With Chronic Myeloid Leukemia
- Conditions
- Chronic Myeloid Leukemia, Chronic PhaseChronic Myeloid Leukemia
- Interventions
- First Posted Date
- 2023-12-08
- Last Posted Date
- 2025-01-27
- Lead Sponsor
- Terns, Inc.
- Target Recruit Count
- 100
- Registration Number
- NCT06163430
- Locations
- 🇺🇸
UC Irvine Health, Orange, California, United States
🇺🇸Rocky Mountain Cancer Centers, LLP, Lone Tree, Colorado, United States
🇺🇸Georgia Cancer Center at Augusta University, Augusta, Georgia, United States
DUET Study: A Clinical Study to Evaluate the Safety, Efficacy, Pharmacokinetics and Pharmacodynamics of Orally Administered TERN-501 as Monotherapy and in Combination With TERN-101 in Noncirrhotic Adults With Presumed Non-Alcoholic Steatohepatitis
- Conditions
- NASH - Nonalcoholic Steatohepatitis
- Interventions
- First Posted Date
- 2022-06-13
- Last Posted Date
- 2025-03-12
- Lead Sponsor
- Terns, Inc.
- Target Recruit Count
- 162
- Registration Number
- NCT05415722
- Locations
- 🇺🇸
Site 1003: Clinical Trials of Texas, LLC, San Antonio, Texas, United States
🇺🇸Site 1006: American Research Corporation, San Antonio, Texas, United States
🇺🇸Site 1053 Bon Secours Richmond Community Hospital LLC d/b/a Bon Secours Liver Institute of Richmond, Richmond, Virginia, United States
AVIATION Study: A Safety, Pharmacokinetics, Pharmacodynamics and Preliminary Efficacy Study of TERN-201 in Patients With Non-Cirrhotic Non-Alcoholic Steatohepatitis
- Conditions
- NASH - Nonalcoholic Steatohepatitis
- Interventions
- Other: Placebo
- First Posted Date
- 2021-05-21
- Last Posted Date
- 2024-06-07
- Lead Sponsor
- Terns, Inc.
- Target Recruit Count
- 52
- Registration Number
- NCT04897594
- Locations
- 🇺🇸
Terns Clinical Study Site 1018, Tucson, Arizona, United States
🇺🇸Terns Clinical Study Site 1024, Tucson, Arizona, United States
🇺🇸Terns Clinical Study Site 1001, Panorama City, California, United States
LIFT Study: A Safety, Tolerability, Efficacy, and Pharmacokinetics Study of TERN-101 in Subjects With Non-Cirrhotic Non-Alcoholic Steatohepatitis (NASH)
- Conditions
- NASH - Nonalcoholic Steatohepatitis
- Interventions
- Other: Placebo
- First Posted Date
- 2020-03-31
- Last Posted Date
- 2022-08-09
- Lead Sponsor
- Terns, Inc.
- Target Recruit Count
- 101
- Registration Number
- NCT04328077
- Locations
- 🇺🇸
Terns Clinical Study Site 1002, Baltimore, Maryland, United States
🇺🇸Terns Clinical Study Site 1028, Hialeah, Florida, United States
🇺🇸Terns Clinical Study Site 1007, Hialeah, Florida, United States